Bay­er-owned AskBio will shift fo­cus to­ward its dog­gy­bone DNA in re­struc­ture with Touch­light

4 years ago
Pharma
Manufacturing

Te­va ex­ecs claim mixed win­ning streak in pricey opi­oids court bat­tle — as per­ma­nent peace re­mains elu­sive

4 years ago
Pharma

Gener­ics on the way? Top drugs in dan­ger of los­ing patent pro­tec­tion

4 years ago
Pharma

In­cyte CEO Hervé Hop­penot sees block­buster po­ten­tial for Opzelu­ra, even as an­a­lysts shake their heads in doubt

4 years ago
Pharma

French biotech lands man­u­fac­tur­ing deal in step to­ward com­mer­cial­iza­tion of rare bone dis­ease drug

4 years ago
Pharma
Manufacturing

Hal Bar­ron’s swan song as GSK R&D chief ends with a promise: The best is yet to come

4 years ago
R&D

FDA+ roundup: Biden's sci­en­tif­ic lead­er­ship in ma­jor flux; Cures 2.0 and ARPA-H to be pack­aged to­geth­er

4 years ago
FDA+

Back­ing Bio­gen, 75+ House Re­pub­li­cans call on CMS to aban­don its de­ci­sion to lim­it amy­loid-tar­get­ed Alzheimer's drugs ...

4 years ago
Pharma

Bio­Marin lands $110m sale of pri­or­i­ty re­view vouch­er; Hy­bridize li­cens­es out BK virus ther­a­py

4 years ago
News Briefing

Ed­i­to­r­i­al: Did Rick Paz­dur's big 'no' on Lil­ly's Chi­na-born PD-1 al­so spell the end for price dis­rup­tion?

4 years ago
FDA+

Mer­ck KGaA en­lists lit­tle AI play­er on pro­tein de­grad­er dis­cov­ery

4 years ago
Deals
AI

Up­dat­ed: RA Cap­i­tal and Soft­Bank head up the lat­est nine-fig­ure crossover, this time for Ven­tus. Will an IPO soon ...

4 years ago
Financing

Pre­ma­ture birth drug saga drags on as Co­vis ques­tions fair­ness of FDA hear­ing

4 years ago
FDA+

With first hu­man da­ta, long-strug­gling Si­lence Ther­a­peu­tics leaps in­to next big car­dio­vas­cu­lar race

4 years ago
R&D

Two Pan­dion vets jump back in­to the start­up world, this time us­ing ma­chine learn­ing to build bet­ter im­munol­o­gy drugs

4 years ago
Startups
Discovery

Tak­ing on Big Phar­ma-sized in­di­ca­tions, tiny biotech claims ear­ly win in fat loss. Will it trans­late to di­a­betes, ...

4 years ago
R&D

Af­ter Q4 sales sink, Am­gen CEO Bob Brad­way de­tails lofty growth strat­e­gy for 2030: Can he pull it off?

4 years ago
Pharma

No­vavax's vac­cine roll­out crawls amid months of bro­ken promis­es — re­port

4 years ago
Pharma
Coronavirus

GAO re­port calls on FDA to re­duce in­spec­tor turnover both home and abroad

4 years ago
Pharma
Manufacturing

Al­bert Bourla has some plans for Pfiz­er's huge Covid cash haul. Hint: 'Ac­qui­si­tions are very much in the card­s'

4 years ago
Deals
Pharma

Covid-19 jab pro­duc­tion has stopped at J&J's vac­cine birth­place

4 years ago
Coronavirus
Manufacturing

Aduhelm reignites ques­tions around ties be­tween phar­ma and pa­tient ad­vo­ca­cy orgs

4 years ago
Pharma
Marketing

Bris­tol My­ers Squibb, Pfiz­er re­new ap­peal for heart symp­tom checks in ‘No Time to Wait’ cam­paign

4 years ago
Pharma
Marketing

Mar­ket­ingRx roundup: Ab­b­Vie de­buts Qulip­ta mi­graine TV ads; Lil­ly fo­cus­es on Olympic ath­lete in boy­cotted Games

4 years ago
Pharma
Marketing
First page Previous page 577578579580581582583 Next page Last page
A service from the Financial Times